| Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2389 | 2019 |
| Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis JU Scher, A Sczesnak, RS Longman, N Segata, C Ubeda, C Bielski, ... elife 2, e01202, 2013 | 1885 | 2013 |
| The genomic landscape of endocrine-resistant advanced breast cancers P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross, N Vasan, Y Cai, ... Cancer cell 34 (3), 427-438. e6, 2018 | 799 | 2018 |
| The long tail of oncogenic drivers in prostate cancer J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ... Nature genetics 50 (5), 645-651, 2018 | 734 | 2018 |
| Integrative molecular characterization of malignant pleural mesothelioma J Hmeljak, F Sanchez-Vega, KA Hoadley, J Shih, C Stewart, D Heiman, ... Cancer discovery 8 (12), 1548-1565, 2018 | 488 | 2018 |
| Genome doubling shapes the evolution and prognosis of advanced cancers CM Bielski, A Zehir, AV Penson, MTA Donoghue, W Chatila, J Armenia, ... Nature genetics 50 (8), 1189-1195, 2018 | 486 | 2018 |
| MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells GV Kryukov, FH Wilson, JR Ruth, J Paulk, A Tsherniak, SE Marlow, ... Science 351 (6278), 1214-1218, 2016 | 463 | 2016 |
| Tumour lineage shapes BRCA-mediated phenotypes P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ... Nature 571 (7766), 576-579, 2019 | 338 | 2019 |
| Accelerating discovery of functional mutant alleles in cancer MT Chang, TS Bhattarai, AM Schram, CM Bielski, MTA Donoghue, ... Cancer discovery 8 (2), 174-183, 2018 | 309 | 2018 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 281 | 2022 |
| KRAS allelic imbalance enhances fitness and modulates MAP kinase dependence in cancer MR Burgess, E Hwang, R Mroue, CM Bielski, AM Wandler, BJ Huang, ... Cell 168 (5), 817-829. e15, 2017 | 178 | 2017 |
| Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors H Janouskova, G El Tekle, E Bellini, ND Udeshi, A Rinaldi, A Ulbricht, ... Nature medicine 23 (9), 1046-1054, 2017 | 165 | 2017 |
| TERT promoter mutations and monoallelic activation of TERT in cancer FW Huang, CM Bielski, ML Rinne, WC Hahn, WR Sellers, F Stegmeier, ... Oncogenesis 4 (12), e176-e176, 2015 | 94 | 2015 |
| Widespread selection for oncogenic mutant allele imbalance in cancer CM Bielski, MTA Donoghue, M Gadiya, AJ Hanrahan, HH Won, ... Cancer cell 34 (5), 852-862. e4, 2018 | 90 | 2018 |
| The evolutionary origins of recurrent pancreatic cancer H Sakamoto, MA Attiyeh, JM Gerold, AP Makohon-Moore, A Hayashi, ... Cancer discovery 10 (6), 792-805, 2020 | 77 | 2020 |
| The context-specific role of germline pathogenicity in tumorigenesis P Srinivasan, C Bandlamudi, P Jonsson, Y Kemel, SS Chavan, ... Nature genetics 53 (11), 1577-1585, 2021 | 59 | 2021 |
| The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers EY Rosen, HH Won, Y Zheng, E Cocco, D Selcuklu, Y Gong, ... Nature communications 13 (1), 1450, 2022 | 58 | 2022 |
| Integrated genetic and pharmacologic interrogation of rare cancers AL Hong, YY Tseng, GS Cowley, O Jonas, JH Cheah, BD Kynnap, ... Nature communications 7 (1), 11987, 2016 | 53 | 2016 |
| Accelerating discovery of functional mutant alleles in cancer. Cancer Discov. 2018; 8: 174–183. doi: 10.1158/2159-8290 MT Chang, TS Bhattarai, AM Schram, CM Bielski, MTA Donoghue, ... CD-17-0321.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 49 | |
| Phase and context shape the function of composite oncogenic mutations AN Gorelick, FJ Sánchez-Rivera, Y Cai, CM Bielski, E Biederstedt, ... Nature 582 (7810), 100-103, 2020 | 36 | 2020 |
